Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2021
Jul. 31, 2020
 OPERATING EXPENSES    
 Research and development $ 916,408 $ 308,846
 General and administrative 1,389,831 1,009,461
 Total operating expenses 2,306,239 1,318,307
 Loss from operations (2,306,239) (1,318,307)
 OTHER INCOME (EXPENSE), NET    
 Interest expense (13,628) (151)
 Interest income - related party 1,706
 Total other income (expense), net (13,628) 1,555
 NET LOSS $ (2,319,867) $ (1,316,752)
 Basic and diluted net loss per common share $ (0.03) $ (0.02)
 Basic and diluted weighted average common  shares outstanding 84,588,492 72,262,858